Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor

Molecular and Cellular Biology

Volumn 34, Issue 2, 2014, Pages 196-209

  Ostler, Nicole ^a   Britzen Laurent, Nathalie ^a   Liebl, Andrea ^a   Naschberger, Elisabeth ^a   Lochnit, Günter ^b   Ostler, Markus ^c   Forster, Florian ^d   Kunzelmann, Peter ^e   Ince, Semra ^f   Supper, Verena ^d   Praefcke, Gerrit J K ^g   Schubert, Dirk W ^e   Stockinger, Hannes ^d   Herrmann, Christian ^f   Stürzl, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c CHEMNITZ UNIVERSITY OF TECHNOLOGY   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IMMUNOREGULATION; LIGHT SCATTERING; MASS SPECTROMETRY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEOMICS; SILVER STAINING; TRANSIENT EXPRESSION; WESTERN BLOTTING;

EID: 84891385411     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00664-13     Document Type: Article

References (79)

1. Damsker JM, Hansen AM, Caspi RR. 2010. Th1 and Th17 cells: adversaries and collaborators. Ann. N. Y. Acad. Sci. 1183:211-221. http://dx.doi.org/10.1111/j.1749-6632.2009.05133.x.
2. Ikeda H, Old LJ, Schreiber RD. 2002. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13:95-109. http://dx.doi.org/10.1016/S1359-6101(01)00038-7.
3. Bach EA, Aguet M, Schreiber RD. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591. http://dx.doi.org/10.1146/annurev.immunol.15.1.563.
4. Farrar MA, Schreiber RD. 1993. The molecular cell biology of interferongamma and its receptor. Annu. Rev. Immunol. 11:571-611. http://dx.doi.org/10.1146/annurev.iy.11.040193.003035.
5. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264. http://dx.doi.org/10.1146/annurev.biochem.67.1.227.
6. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147:258-267. http://dx.doi.org/10.1098/rspb.1957.0048.
7. Samuel CE. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809. http://dx.doi.org/10.1128/CMR.14.4.778-809.2001.
8. Shtrichman R, Samuel CE. 2001. The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 4:251-259. http://dx.doi.org/10.1016/S1369-5274(00)00199-5.
9. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD. 2011. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 332:717-721. http://dx.doi.org/10.1126/science.1201711.
10. Dunn GP, Koebel CM, Schreiber RD. 2006. Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6:836-848. http://dx.doi.org/10.1038/nri1961.
11. Dunn GP, Old LJ, Schreiber RD. 2004. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22:329-360. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104803.
12. Fridman WH, Dieu-Nosjean MC, Pages F, Cremer I, Damotte D, Sautes-Fridman C, Galon J. 2013. The immune microenvironment of human tumors: general significance and clinical impact. Cancer Microenviron. 6:117-122. http://dx.doi.org/10.1007/s12307-012-0124-9.
13. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. 1998. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. U. S. A. 95:7556-7561. http://dx.doi.org/10.1073/pnas.95.13.7556.
14. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111. http://dx.doi.org/10.1038/35074122.
15. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. 1997. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17:5328-5337.
16. Detjen KM, Farwig K, Welzel M, Wiedenmann B, Rosewicz S. 2001. Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49:251-262. http://dx.doi.org/10.1136/gut.49.2.251.
17. Britzen-Laurent N, Lipnik K, Ocker M, Naschberger E, Schellerer VS, Croner RS, Vieth M, Waldner M, Steinberg P, Hohenadl C, Stürzl M. 2013. GBP-1 acts as a tumor suppressor in colorectal cancer cells. Carcinogenesis 34:153-162. http://dx.doi.org/10.1093/carcin/bgs310.
18. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE, Jr. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. U. S. A. 93:7673-7678. http://dx.doi.org/10.1073/pnas.93.15.7673.
19. Capaldo CT, Beeman N, Hilgarth RS, Nava P, Louis NA, Naschberger E, Stürzl M, Parkos CA, Nusrat A. 2012. IFN-γ and TNF-α-induced GBP-1 inhibits epithelial cell proliferation through suppression of β-catenin/TCF signaling. Mucosal Immunol. 5:681-690. http://dx.doi.org/10.1038/mi.2012.41.
20. Tong Q, Vassilieva EV, Ivanov AI, Wang Z, Brown GT, Parkos CA, Nusrat A. 2005. Interferon-gamma inhibits T84 epithelial cell migration by redirecting transcytosis of beta1 integrin from the migrating leading edge. J. Immunol. 175:4030-4038.
21. Cheng YS, Colonno RJ, Yin FH. 1983. Interferon induction of fibroblast proteins with guanylate binding activity. J. Biol. Chem. 258:7746-7750.
22. Lubeseder-Martellato C, Guenzi E, Jörg Töpolt AK, Naschberger E, Kremmer E, Zietz C, Tschachler E, Hutzler P, Schwemmle M, Matzen K, Grimm T, Ensoli B, Stürzl M. 2002. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am. J. Pathol. 161:1749-1759. http://dx.doi.org/10.1016/S0002-9440(10)64452-5.
23. Praefcke GJ, McMahon HT. 2004. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat. Rev. Mol. Cell Biol. 5:133-147. http://dx.doi.org/10.1038/nrm1313.
24. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. 2000. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403:567-571. http://dx.doi.org/10.1038/35000617.
25. Kunzelmann S, Praefcke GJ, Herrmann C. 2006. Transient kinetic investigation of GTP hydrolysis catalyzed by interferon-gamma-induced hGBP1 (human guanylate binding protein 1). J. Biol. Chem. 281:28627-28635. http://dx.doi.org/10.1074/jbc. M604911200.
26. Praefcke GJ, Geyer M, Schwemmle M, Robert Kalbitzer H, Herrmann C. 1999. Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP1) and identification of the third GTP-binding motif. J. Mol. Biol. 292:321-332. http://dx.doi.org/10.1006/jmbi.1999.3062.
27. Syguda A, Bauer M, Benscheid U, Ostler N, Naschberger E, Ince S, Stürzl M, Herrmann C. 2012. Tetramerization of human guanylatebinding protein 1 is mediated by coiled-coil formation of the C-terminal alpha-helices. FEBS J. 279:2544-2554. http://dx.doi.org/10.1111/j.1742-4658.2012.08637.x.
28. Vöpel T, Syguda A, Britzen-Laurent N, Kunzelmann S, Lüdemann MB, Dovengerds C, Stürzl M, Herrmann C. 2010. Mechanism of GTPaseactivity-induced self-assembly of human guanylate binding protein 1. J. Mol. Biol. 400:63-70. http://dx.doi.org/10.1016/j.jmb.2010.04.053.
29. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M. 2009. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50:1727-1737. http://dx.doi.org/10.1002/hep.23195.
30. Tietzel I, El-Haibi C, Carabeo RA. 2009. Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. PLoS One 4:e6499. http://dx.doi.org/10.1371/journal.pone.0006499.
31. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Wurthner J, Kurig S, Beer S, Pfeffer K. 2007. Extensive characterization of IFNinduced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179:7729-7740.
32. Selleck EM, Fentress SJ, Beatty WL, Degrandi D, Pfeffer K, Virgin HW, IV, Macmicking JD, Sibley LD. 2013. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog. 9:e1003320. http://dx.doi.org/10.1371/journal.ppat.1003320.
33. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati-Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferongamma-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302-313. http://dx.doi.org/10.1016/j.immuni.2012.06.009.
34. Guenzi E, Töpolt K, Cornali E, Lubeseder-Martellato C, Jörg Matzen AK, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, Stürzl M. 2001. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 20:5568-5577. http://dx.doi.org/10.1093/emboj/20.20.5568.
35. Guenzi E, Töpolt K, Lubeseder-Martellato C, Jörg Naschberger AE, Benelli R, Albini A, Stürzl M. 2003. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 22:3772-3782. http://dx.doi.org/10.1093/emboj/cdg382.
36. Hammon M, Herrmann M, Bleiziffer O, Pryymachuk G, Andreoli L, Munoz LE, Amann KU, Mondini M, Gariglio M, Airo P, Schellerer VS, Hatzopoulos AK, Horch RE, Kneser U, Stürzl M, Naschberger E. 2011. Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases. J. Cell. Mol. Med. 15:1582-1592. http://dx.doi.org/10.1111/j.1582-4934.2010.01146.x.
37. Lipnik K, Naschberger E, Gonin-Laurent N, Kodajova P, Petznek H, Rungaldier S, Astigiano S, Ferrini S, Stürzl M, Hohenadl C. 2010. Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Mol. Med. 16:177-187. http://dx.doi.org/10.2119/molmed.2009.00172.
38. Messmer-Blust AF, Balasubramanian S, Gorbacheva VY, Jeyaratnam JA, Vestal DJ. 2010. The interferon-gamma-induced murine guanylatebinding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase. Mol. Biol. Cell 21:2514-2528. http://dx.doi.org/10.1091/mbc. E09-04-0344.
39. Naschberger E, Croner RS, Merkel S, Dimmler A, Tripal P, Amann KU, Kremmer E, Brueckl WM, Papadopoulos T, Hohenadl C, Hohenberger W, Stürzl M. 2008. Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int. J. Cancer 123:2120-2129. http://dx.doi.org/10.1002/ijc.23764.
40. Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337. http://dx.doi.org/10.1038/nature11252.
41. Weinländer K, Naschberger E, Lehmann MH, Tripal P, Paster W, Stockinger H, Hohenadl C, Stürzl M. 2008. Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J. 22:4168-4178. http://dx.doi.org/10.1096/fj.08-107524.
42. Britzen-Laurent N, Bauer M, Berton V, Fischer N, Syguda A, Reipschlager S, Naschberger E, Herrmann C, Stürzl M. 2010. Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS One 5:e14246. http://dx.doi.org/10.1371/journal.pone.0014246.
43. Wehner M, Kunzelmann S, Herrmann C. 2012. The guanine cap of human guanylate-binding protein 1 is responsible for dimerization and self-activation of GTP hydrolysis. FEBS J. 279:203-210. http://dx.doi.org/10.1111/j.1742-4658.2011.08415.x.
44. Praefcke GJ, Kloep S, Benscheid U, Lilie H, Prakash B, Herrmann C. 2004. Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis. J. Mol. Biol. 344:257-269. http://dx.doi.org/10.1016/j.jmb.2004.09.026.
45. Chen CA, Okayama H. 1988. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632-638.
46. Naschberger E, Lubeseder-Martellato C, Meyer N, Gessner R, Kremmer E, Gessner A, Stürzl M. 2006. Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. Am. J. Pathol. 169:1088-1099. http://dx.doi.org/10.2353/ajpath.2006.060244.
47. Jaskolski F, Mulle C, Manzoni OJ. 2005. An automated method to quantify and visualize colocalized fluorescent signals. J. Neurosci. Methods 146:42-49. http://dx.doi.org/10.1016/j.jneumeth.2005.01.012.
48. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
49. Naldi M, Vasina E, Dobroiu S, Paraoan L, Nicolau DV, Andrisano V. 2009. Self-assembly of biomolecules: AFM study of F-actin on unstructured and nanostructured surfaces. Proc. SPIE 7188:Q7-Q9. http://dx.doi.org/10.1117/12.822800.
50. Pastre D, Pietrement O, Fusil S, Landousy F, Jeusset J, David MO, Hamon L, Le Cam E, Zozime A. 2003. Adsorption of DNA to mica mediated by divalent counterions: a theoretical and experimental study. Biophys. J. 85:2507-2518. http://dx.doi.org/10.1016/S0006-3495(03)74673-6.
51. Horcas I, Fernandez R, Gomez-Rodriguez JM, Colchero J, Gomez-Herrero J, Baro AM. 2007. WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev. Sci. Instrum. 78:013705. http://dx.doi.org/10.1063/1.2432410.
52. Tripal P, Bauer M, Naschberger E, Mortinger T, Hohenadl C, Cornali E, Thurau M, Stürzl M. 2007. Unique features of different members of the human guanylate-binding protein family. J. Interferon Cytokine Res. 27:44-52. http://dx.doi.org/10.1089/jir.2007.0086.
53. Asakawa H, Miyagawa J, Hanafusa T, Katsura H, Miyazaki A, Otsuka A, Nakagawa C, Yamagata K, Tajima K, Mashita K, Kono N, Tarui S. 1990. Interferon-gamma reduces actin filaments and inhibits thyroidstimulating hormone-induced formation of microvilli and pseudopods in mouse monolayer thyrocytes. Endocrinology 127:325-329. http://dx.doi.org/10.1210/endo-127-1-325.
54. Molony L, Armstrong L. 1991. Cytoskeletal reorganizations in human umbilical vein endothelial cells as a result of cytokine exposure. Exp. Cell Res. 196:40-48. http://dx.doi.org/10.1016/0014-4827(91)90454-3.
55. Muros MA, Aranega AE, Velez C, Melguizo C, Alvarez L, Aranega A. 1994. Modulation of contractile proteins in embryonic and fetal chick cardiac cells by phorbol ester, gamma-interferon, 5-azacytidine and diacylglycerols. Life Sci. 54:171-183. http://dx.doi.org/10.1016/0024-3205(94)00586-9.
56. Surin B, Rouillard D, Bauvois B. 2000. Loss of alpha5beta1-mediated adhesion of monocytic cells to fibronectin by interferons beta and gamma is associated with changes in actin and paxillin cytoskeleton. Hematol. J. 1:172-180. http://dx.doi.org/10.1038/sj.thj.6200027.
57. Coué M, Brenner SL, Spector I, Korn ED. 1987. Inhibition of actin polymerization by latrunculin A. FEBS Lett. 213:316-318. http://dx.doi.org/10.1016/0014-5793(87)81513-2.
58. Schliwa M. 1982. Action of cytochalasin D on cytoskeletal networks. J. Cell Biol. 92:79-91. http://dx.doi.org/10.1083/jcb.92.1.79.
59. Kurth MC, Wang LL, Dingus J, Bryan J. 1983. Purification and characterization of a gelsolin-actin complex from human platelets. Evidence for Ca2
60. Ikawa T, Hoshino F, Watanabe O, Li Y, Pincus P, Safinya CR. 2007. Molecular scale imaging of F-actin assemblies immobilized on a photopolymer surface. Phys. Rev. Lett. 98:018101. http://dx.doi.org/10.1103/PhysRevLett.98.018101.
61. Sharma S, Grintsevich EE, Phillips ML, Reisler E, Gimzewski JK. 2011. Atomic force microscopy reveals drebrin induced remodeling of F-actin with subnanometer resolution. Nano Lett. 11:825-827. http://dx.doi.org/10.1021/nl104159v.
62. Zhang J, Wang YL, Gu L, Pan J. 2003. Atomic force microscopy of actin. ShengWuHua Xue Yu ShengWuWuLi Xue Bao (Shanghai) 35:489-494.
63. Czurylo EA, Eimer W, Kulikova N, Hellweg T. 2000. Size, shape and secondary structure of calponin. Acta Biochim. Pol. 47:791-806.
64. Pivovarova AV, Chebotareva NA, Chernik IS, Gusev NB, Levitsky DI. 2007. Small heat shock protein Hsp27 prevents heat-induced aggregation of F-actin by forming soluble complexes with denatured actin. FEBS J. 274:5937-5948. http://dx.doi.org/10.1111/j.1742-4658.2007.06117.x.
65. Cooper JA, Walker SB, Pollard TD. 1983. Pyrene actin: documentation of the validity of a sensitive assay for actin polymerization. J. Muscle Res. Cell Motil. 4:253-262. http://dx.doi.org/10.1007/BF00712034.
66. Naschberger E, Werner T, Vicente AB, Guenzi E, Töpolt K, Leubert R, Lubeseder-Martellato C, Nelson PJ, Stürzl M. 2004. Nuclear factorkappaB motif and interferon-alpha-stimulated response element cooperate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem. J. 379:409-420. http://dx.doi.org/10.1042/BJ20031873.
67. De Donato M, Mariani M, Petrella L, Martinelli E, Zannoni GF, Vellone V, Ferrandina G, Shahabi S, Scambia G, Ferlini C. 2012. Class III beta-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. J. Cell. Physiol. 227:1034-1041. http://dx.doi.org/10.1002/jcp.22813.
68. Naschberger E, Bauer M, Stürzl M. 2005. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases. Adv. Enzyme Regul. 45:215-227. http://dx.doi.org/10.1016/j.advenzreg.2005.02.011.
69. Olszewski MA, Gray J, Vestal DJ. 2006. In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. J. Interferon Cytokine Res. 26:328-352. http://dx.doi.org/10.1089/jir.2006.26.328.
70. Cooper JA, Sept D. 2008. New insights into mechanism and regulation of actin capping protein. Int. Rev. Cell Mol. Biol. 267:183-206. http://dx.doi.org/10.1016/S1937-6448(08)00604-7.
71. Pollard TD, Borisy GG. 2003. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112:453-465. http://dx.doi.org/10.1016/S0092-8674(03)00120-X.
72. Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D. 2004. Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci. 61:2614-2623. http://dx.doi.org/10.1007/s00018-004-4225-6.
73. Weeds A, Maciver S. 1993. F-actin capping proteins. Curr. Opin. Cell Biol. 5:63-69. http://dx.doi.org/10.1016/S0955-0674(05)80009-2.
74. Spector I, Shochet NR, Blasberger D, Kashman Y. 1989. Latrunculins- novel marine macrolides that disrupt microfilament organization and affect cell growth. I. Comparison with cytochalasin D. Cell Motil. Cytoskeleton 13:127-144. http://dx.doi.org/10.1002/cm.970130302.
75. Ivanov AI, Parkos CA, Nusrat A. 2010. Cytoskeletal regulation of epithelial barrier function during inflammation. Am. J. Pathol. 177:512-524. http://dx.doi.org/10.2353/ajpath.2010.100168.
76. Youakim A, Ahdieh M. 1999. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 276:G1279-G1288.
77. Schnoor M, Betanzos A, Weber DA, Parkos CA. 2009. Guanylatebinding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Mucosal Immunol. 2:33-42. http://dx.doi.org/10.1038/mi.2008.62.
78. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514. http://dx.doi.org/10.1126/science.279.5350.509.
79. Ridley AJ. 2001. Rho GTPases and cell migration. J. Cell Sci. 114:2713-2722.